Worst performer was KIBO:Kibo Mining, dropping 9% and back below 5p. This is 32% down since purchase but I still believe it will re-rate significantly once the final agreements for the power station come through. I would top up, but it's still quite high risk and I've invested enough already.
I'm still worried about TRX:Tissue Regenix which fell another 6% and is now down by 54%. I had such high hopes, but they seem to be struggling to earn revenue despite having a fantastic product. The CEO has stepped down so maybe there's an opportunity for someone with more of a head for commercialisation to take over. Normally I'd be topping up after a dip of this magnitude, but I'm not convinced enough to take the risk.
Better performance for SBTX:SkinBioTherapeutics this week, climbing 6% but still losing 28% on purchase price. The only reason I'm not increasing my holding at this price is the promise of free shares from OPTI:Optibiotix which will satisfy my desire to hold more. OPTI:Optibiotix themselves climbed 2p and ensured the portfolios stayed in the black for the week. When will it finally break out of this 2-year trading range?
Share of the Week is TLOU:Tlou Energy which climbed 11% but is still 2% away from break-even. I'm expecting this to double in the next 6 months and would buy more if I had the cash.
Looks like we've been pretty much level for almost a month now. Compared to the volatility prior to that, it's been a very quiet time.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £39.59 | +£0 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £47,708.58 | (+7.4%) | +£112.67 |
| Potential profits | £8,479.42 | -£345.27 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £209.91 | (5.7%) | -£20.99 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £315.17 | (8.5%) | -£2.76 |
| (Sold stocks profit + Dividends - Fees / Months) |
A small increase in value mainly from reduced losses, as potential profits were savaged by drops in AMYT:Amryt Pharma, IQE:IQE, MTFB:Motif Bio and RED:RedT Energy. These are a significant proportion of my best shares so it was a tad upsetting they all had a bad week.
Very similar to the overall graph yet again, with a nice consolidation in the black.
The SIPP looks like this after week 99
| Weekly Change | |||
| Cash | £44.63 | +£0 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,502.73 | (9.1%) | +£407.55 |
| Potential profits | £3,575.07 | +£514.25 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £628.61 | (29.9%) | -£13.66 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £417.15 | (19.8%) | -£4.26 |
| (Sold stocks profit + Dividends - Fees / Months) |
Much better performance this week largely thanks to increasing profits for CAML:Central Asia Metals, OPTI:Optibiotix and LGEN:Legal & General. Those rises were offset by deepening losses in ARL:Atlantis Resources and TRX:Tissue Regenix which caused the value to increase by less than the increase in paper profits.
Just a little bit more of an upward trend on this chart. I'd be happy if it stays like that for a few months.
The trading account looks like this after week 65
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £363.35 | (-25.2%) | -£2.78 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.45 | (-3.6%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Nothing to say - just want to sell and start again from scratch!
So frustrating - if I ever do this properly I'll look back on this period and giggle hysterically
Last week I predicted this would be a dull one and I think I was right. The only excitement was IQE:IQE revealing they had "discovered" £4.2m of unpaid taxes from a company they bought out a few years back. I feared the worst, but the share price was hardly dented, showing that people are looking past a few million to the massive profits that are not too far ahead.
There was some further excitement after hours when AFPO:African Potash finally came out of hiding, announced final results and gave up on their potential purchase of another company. The suspension on the shares will be lifted on Monday morning. Given their annual report revealed net income of $9,000 from trading for the whole year and an operating loss of $1.9m, I doubt there's going to be a queue of people waiting to buy! My only hope is they'll make something from farming out Lac Dinga else I'll never see my money again.
Next week will see a few dividends appear. CMCL:Caledonia Mining are paying out around £10 on Friday as the quarterly dividend, but it may not hit my account in time for the weekend update. CAML:Central Asia Metals are paying out around £174 as the interim dividend, also on Friday so again it may not arrive in time for the review.
No results expected next week, so once again there's nothing to prepare for other than surprises...
No comments:
Post a Comment